2026-10-25
Trimble clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 29,813 +0.55%
S&P 7,744 +0.28%
GOLD $4,077 +0.07%
BTC $81,598 +0.98%
VIX 16.87 −3.71%
latest tape · as of 20:04 UTC
The Screen · Technology · Scientific & Technical Instruments
Trimble Inc.
TRMB · a US exchange · USD · Market cap $13.9B · 11,500 employees
Trimble Inc.
Not yet scored63.49 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago
Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price63.49 USD at the 23 Oct 2026 close
- Our ratingFair value, current read accumulation
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.52)
- Last reviewed23 Oct 2026 (5 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 63.49 against the desk's fair-value range, base estimate 72.48, over the last year.
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.52, read 2026-10-27
- Ethical screen not yet scored
Price63.49 USD
Fair value72.48
Ethical score88.9/100
RatingFAIR VALUE
Our investment reviews on this name
2026-10-11Read Accumulation57.34+10.7% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-10-02Read Markdown57.34+10.7% to today Markup gives way to Markdown
2026-08-15Read Markup58.55+8.4% to today ✓Distribution gives way to Markup after an 8% rise in 6 weeks
2026-07-02Read Distribution54.19+17.2% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
Trimble Inc. holds its Accumulation at $63.49. Consolidating, no directional conviction, held for 43 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 43 days |
| Price at the screen | $63.49 |
| Valuation | N/A trailing · 14.37 forward price to earnings |
| Values screen | Not scored · score 88.9 |
| Beta | 1.34 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 14.95% | Below 33% | Interest-bearing debt is just 15.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 6.56% | Below 33% | Cash held in interest-bearing accounts and securities is 6.6% of assets, under the one-third limit. | Pass |
| Receivables | 11.91% | Below 49% | Money owed to the company is 11.9% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Trimble clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Trimble clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 15%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads FAIR VALUE: it trades at roughly a 22% discount to our $72.48 fair value, narrow competitive moat, 11.00% revenue growth.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 21.9% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Strong Buy. The average target sits +26% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsConstruction sites finally get joined up tech
Picture a surveyor on site whose measurements flow straight into the architect's model without a single spreadsheet in between. Trimble stitches those workflows together across building, agriculture and transport, and the numbers show it scaling nicely. Revenue is rising 12 percent a year, margins sit at 12 percent, and the shares trade on just 12.9 times forward earnings against a fair value that implies 78 percent upside.
The narrow moat and 8 percent return on equity keep expectations realistic, yet the ethical screen is clean and twelve analysts still cluster around an 82 dollar median target. At 52.72 dollars the valuation leaves room for steady compounding if execution holds.
Cyclical end markets can still bite when project spending slows, and the modest profitability means any slip in growth would compress the multiple quickly. Analysis, not advice.
| Forward P/E | 14.4xpriced for continued growth |
| EPS, trailing | -0.48 |
| EPS, forward | 4.14 |
| Revenue growth | +11.0%steady growth |
| Profit margin | -2.8%currently unprofitable |
| Return on equity | -1.9%not currently earning a positive return on equity |
| FCF yield | 4.95% |
| Debt to equity | 0.29minimal debt: a conservative balance sheet |
| Current ratio | 0.95below 1: short-term bills exceed liquid assets |
| Beta | 1.34moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 47.92 - 84.42 |
| Moat | NARROW |
| Market cap | $13.9B |
| Employees | 11,500 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTRMB trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-28
Accumulation $59.46
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Accumulation $59.46
+0.0% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-10-18
Accumulation $59.46
+3.7% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-10-11
Accumulation · changed $57.34
+0.0% Entry 7
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-10-02
Markdown · changed $57.34
+0.9% Entry 6
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-09-15
Markup $56.84
-2.9% Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-08-15
Markup · changed $58.55
+8.0% Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-07-18
Distribution $54.19
+0.0% Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-07-03
Distribution $54.19
+0.0% Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02
Distribution $54.19
Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Trimble (TRMB) Stock Trades At A Discount On Its 38% Run Yahoo Finance · 4d ago
- Can Manhattan Associates Stock Compound Your Money? Yahoo Finance · 5d ago
- Trimble Earnings Preview: What to Expect Yahoo Finance · 6d ago
- Can Autodesk Stock Bounce Off The Current Support? Yahoo Finance · 6d ago
- Why Did Planet Labs Stock Fall? Yahoo Finance · 7d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
MKSIMKS Inc
FTVFortive
CGNXCognex Corp
TDYTeledyne Technologies
ESEESCO Technologies Inc.
STSensata Technologies Holding plc
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-16 | SCHWARTZ MARK DAVID | Officer | 16,725 | $1,120,742 | |
| 2026-04-15 | SAWARYNSKI PHILLIP | Chief Financial Officer | 3,895 | $259,056 | |
| 2026-04-15 | KEATING CHRISTOPHER F | Officer | 9,778 | $650,335 | |
| 2026-04-15 | PAINTER ROBERT G | Chief Executive Officer | 187,746 | $12,486,986 | |
| 2026-04-15 | BISIO RONALD | Officer | 18,252 | $1,213,941 | |
| 2026-04-15 | LARGE PETER | Officer | 18,252 | $1,213,941 | |
| 2026-04-15 | ALLISON JENNIFER | General Counsel | 9,452 | $628,653 | |
| 2026-04-15 | SCHWARTZ MARK DAVID | Officer | 14,342 | $953,886 | |
| 2026-04-15 | LARGE PETER | Officer | 6,582 | · | |
| 2026-04-15 | ALLISON JENNIFER | General Counsel | 4,798 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $58.04 | -12.8% | · | $872 | -12.8% |
| 2 months | $64.77 | -21.9% | · | $781 | -21.9% |
| 3 months | $66.16 | -23.5% | · | $765 | -23.5% |
| 6 months | $83.34 | -39.3% | · | $607 | -39.3% |
| 1 year | $72.80 | -30.5% | · | $695 | -30.5% |
| 2 years | $55.36 | -8.6% | · | $914 | -8.6% |
| 3 years | $50.11 | +1.0% | · | $1,010 | +1.0% |
| 5 years | $78.61 | -35.6% | · | $644 | -35.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TRMB does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.